Legal Representation
Attorney
Rebecca E. McDougall
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 24, 2021 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Feb 24, 2021 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Feb 24, 2021 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Feb 22, 2021 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | Loading... |
| Aug 24, 2020 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | Loading... |
| Aug 21, 2020 | PCGR | O | PETITION TO DIRECTOR GRANTED | Loading... |
| Aug 21, 2020 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Aug 21, 2020 | REIN | I | REINSTATED | Loading... |
| Aug 21, 2020 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Aug 17, 2020 | ERTI | I | TEAS RESPONSE TO PETITION INQUIRY LETTER | Loading... |
| Jul 29, 2020 | PILM | I | PETITION INQUIRY LETTER ISSUED | Loading... |
| Jul 28, 2020 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Apr 6, 2020 | TPDR | I | TEAS PETITION TO DIRECTOR RECEIVED | Loading... |
| Mar 27, 2020 | NCS8 | E | NOTICE OF CANCELLATION SEC. 8 EMAILED | Loading... |
| Mar 26, 2020 | C8.T | O | CANCELLED SEC. 8 (10-YR) | Loading... |
| Sep 25, 2019 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 | Loading... |
| Sep 24, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Sep 16, 2019 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Apr 23, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 23, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 15, 2018 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Oct 27, 2015 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Oct 27, 2015 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Oct 27, 2015 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Sep 10, 2015 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Sep 15, 2009 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 11, 2009 | REGV | O | LAW OFFICE REGISTRATION REVIEW COMPLETED | Loading... |
| Aug 10, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jul 31, 2009 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 28, 2009 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 28, 2009 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jul 28, 2009 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 6, 2009 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 6, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 6, 2009 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jul 6, 2009 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jan 15, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 15, 2009 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jan 15, 2009 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jul 23, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 23, 2008 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jul 23, 2008 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 8, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 23, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 23, 2008 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 3, 2007 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 3, 2007 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 3, 2007 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 23, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 31, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Detailed Classifications
Class 005
Medical therapeutic preparations, namely, biologically active modulators, biologically active immune modulators, [ biologically active antisense DNA or RNA compounds, ] chemical modulators of gene expression working at DNA transcription, RNA or translation processes; immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response as a component part in a pharmaceutical preparation; pharmaceutical and vaccine adjuvants to enhance the immune system response; pharmaceuticals for use in the treatment of viral and bacterial infection, inflammatory disorders and diseases, asthma or allergies, cancer, and auto immune diseases and disorders and vaccine adjuvants to modulate the immune system; biologically active pharmaceutical compounds for use in the treatment of viral and bacterial infection or diseases associated with cellular gene expressions by preventing the production of disease associated proteins made by said infectious agents or cellular genes
First Use Anywhere:
Jun 2, 2008
First Use in Commerce:
Jun 2, 2008
Classification
International Classes
005